BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Carcinoma |
📓
A Metagenomic Meta-analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome. mSystems (mSystems ) Vol: 4 Issue 4 Pages: Pub: 2019 Jul-Aug Epub: 2019 May 14 Authors Armour CR , Nayfach S , Pollard KS , Sharpton TJ , Html Article Publication |
| Carcinoma |
📓
Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma. Journal of oral microbiology (J Oral Microbiol ) Vol: 17 Issue 1 Pages: 2594842 Pub: 2025 Epub: 2025 Dec 4 Authors Kim SM , Praveen Z , Kim YH , Ko JH , Choi YS , Park JY , Lee JH , Choi SW , Kim MK , Html Article Publication |
| Carcinoma |
📓
Evaluating the Role of Candida albicans as a Potential Oral Carcinogen. Interdisciplinary perspectives on infectious diseases (Interdiscip Perspect Infect Dis ) Vol: 2025 Issue Pages: 4057977 Pub: 2025 Epub: 2025 Nov 20 Authors Amirinia F , Motamedi M , Ardi P , Jabrodini A , Html Article Publication |
| Carcinoma |
📓
Alterations in the Gut Microbiota of Patients with Esophageal Squamous Cell Carcinoma: A Cross-Sectional Study Conducted in a High-Incidence Region of China. International journal of general medicine (Int J Gen Med ) Vol: 18 Issue Pages: 6507-6522 Pub: 2025 Epub: 2025 Oct 27 Authors Li Y , Guan J , Jing Y , Guo J , Wu Z , Wang Y , Zhou L , Huang R , Zhang Y , Li J , Html Article Publication |
| Carcinoma |
📓
Oral microbial signatures underlying recurrence via PI3K/AKT/mTOR pathway modulation in oral squamous cell carcinoma. Journal of oral microbiology (J Oral Microbiol ) Vol: 17 Issue 1 Pages: 2560020 Pub: 2025 Epub: 2025 Sep 20 Authors Kwack DW , Praveen Z , Kim YH , Yoo CW , Ko JH , Youn SM , Park JY , Lee JH , Choi SW , Kim MK , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
